Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of E5501 by measuring platelet response in subjects with chronic
hepatitis C virus (HCV)-related thrombocytopenia who require antiviral treatment.